BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36747809)

  • 1. A defined clathrin-mediated trafficking pathway regulates sFLT1/VEGFR1 secretion from endothelial cells.
    Kinghorn K; Gill A; Marvin A; Li R; Quigley K; le Noble F; Mac Gabhann F; Bautch VL
    bioRxiv; 2023 Jan; ():. PubMed ID: 36747809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A defined clathrin-mediated trafficking pathway regulates sFLT1/VEGFR1 secretion from endothelial cells.
    Kinghorn K; Gill A; Marvin A; Li R; Quigley K; Singh S; Gore MT; le Noble F; Gabhann FM; Bautch VL
    Angiogenesis; 2024 Feb; 27(1):67-89. PubMed ID: 37695358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion of soluble vascular endothelial growth factor receptor 1 (sVEGFR1/sFlt1) requires Arf1, Arf6, and Rab11 GTPases.
    Jung JJ; Tiwari A; Inamdar SM; Thomas CP; Goel A; Choudhury A
    PLoS One; 2012; 7(9):e44572. PubMed ID: 22962618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C regulates FLT1 abundance and stimulates its cleavage in vascular endothelial cells with the release of a soluble PlGF/VEGF antagonist.
    Raikwar NS; Liu KZ; Thomas CP
    Exp Cell Res; 2013 Oct; 319(17):2578-87. PubMed ID: 23911939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia.
    Sela S; Itin A; Natanson-Yaron S; Greenfield C; Goldman-Wohl D; Yagel S; Keshet E
    Circ Res; 2008 Jun; 102(12):1566-74. PubMed ID: 18515749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFSF15 inhibits vasculogenesis by regulating relative levels of membrane-bound and soluble isoforms of VEGF receptor 1.
    Qi JW; Qin TT; Xu LX; Zhang K; Yang GL; Li J; Xiao HY; Zhang ZS; Li LY
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13863-8. PubMed ID: 23918400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuro-oncological Ventral Antigen 2 Regulates Splicing of Vascular Endothelial Growth Factor Receptor 1 and Is Required for Endothelial Function.
    Kremer V; Oppelaar JJ; Gimbel T; Koziarek S; Ganzevoort W; van Pampus MG; van den Born BJ; Vogt L; de Groot C; Boon RA
    Reprod Sci; 2023 Feb; 30(2):678-689. PubMed ID: 35927413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGFR1 receptor tyrosine kinase localization to the Golgi apparatus is calcium-dependent.
    Mittar S; Ulyatt C; Howell GJ; Bruns AF; Zachary I; Walker JH; Ponnambalam S
    Exp Cell Res; 2009 Mar; 315(5):877-89. PubMed ID: 19162007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of soluble VEGF receptor 1 (sFlt1) by gene electrotransfer as a new antiangiogenic cancer therapy.
    Verrax J; Defresne F; Lair F; Vandermeulen G; Rath G; Dessy C; Préat V; Feron O
    Mol Pharm; 2011 Jun; 8(3):701-8. PubMed ID: 21548585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-angiogenic role of soluble-form VEGF receptor in malignant gliomas.
    Takano S; Ishikawa E; Matsuda M; Sakamoto N; Akutsu H; Yamamoto T; Matsumura A
    Int J Oncol; 2017 Feb; 50(2):515-524. PubMed ID: 28000842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of an anti-angiogenic factor sFLT1 is suppressed via promoter hypermethylation of FLT1 gene in choriocarcinoma cells.
    Sasagawa T; Jinno-Oue A; Nagamatsu T; Morita K; Tsuruga T; Mori-Uchino M; Fujii T; Shibuya M
    BMC Cancer; 2020 Feb; 20(1):112. PubMed ID: 32041578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of BIG1 and BIG2 in regulating VEGF expression and angiogenesis.
    Lu FI; Wang YT; Wang YS; Wu CY; Li CC
    FASEB J; 2019 Sep; 33(9):9959-9973. PubMed ID: 31199673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF1A promotes miR-210/miR-424 transcription to modulate the angiogenesis in HUVECs and HDMECs via sFLT1 under hypoxic stress.
    Zhao H; Wang X; Fang B
    Mol Cell Biochem; 2022 Aug; 477(8):2107-2119. PubMed ID: 35488146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood vessel anastomosis is spatially regulated by Flt1 during angiogenesis.
    Nesmith JE; Chappell JC; Cluceru JG; Bautch VL
    Development; 2017 Mar; 144(5):889-896. PubMed ID: 28246215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis in gestational vascular complications.
    Yagel S
    Thromb Res; 2011 Feb; 127 Suppl 3():S64-6. PubMed ID: 21262445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling.
    Drewlo S; Levytska K; Sobel M; Baczyk D; Lye SJ; Kingdom JC
    J Thromb Haemost; 2011 Dec; 9(12):2486-97. PubMed ID: 21981655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capturing membrane trafficking events during 3D angiogenic development in vitro.
    Francis CR; Kushner EJ
    Microcirculation; 2022 Oct; 29(6-7):e12726. PubMed ID: 34415654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch regulates vascular collagen IV basement membrane through modulation of lysyl hydroxylase 3 trafficking.
    Gross SJ; Webb AM; Peterlin AD; Durrant JR; Judson RJ; Raza Q; Kitajewski JK; Kushner EJ
    Angiogenesis; 2021 Nov; 24(4):789-805. PubMed ID: 33956260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo.
    Krueger J; Liu D; Scholz K; Zimmer A; Shi Y; Klein C; Siekmann A; Schulte-Merker S; Cudmore M; Ahmed A; le Noble F
    Development; 2011 May; 138(10):2111-20. PubMed ID: 21521739
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.